Charles River Laboratories International, Inc.
CRL
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 9 days ago • CRL
Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?Zacks Investment Research • 13 days ago • CRL
Charles River Stock May Gain From Extended CHDI Research Deal on HDZacks Investment Research • 26 days ago • CRL
Should You Continue to Hold Charles River Stock in Your Portfolio?Zacks Investment Research • about a month ago • CRL
Understanding Charles River (CRL) Reliance on International RevenueCNBC • about a month ago • CRL
Activist Elliott reaches key agreement with Charles River. Here are three ways to create valueCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.